| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/23/2014 | US8841268 Method and kit for detection of cancer, and therapeutic agent for cancer |
| 09/23/2014 | US8841260 Methods and compositions for treating Huntington's Disease |
| 09/23/2014 | US8841089 Polynucleotides for enhancing expression of a polynucleotide of interest |
| 09/23/2014 | US8840881 Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer |
| 09/23/2014 | CA2752143C Delivery of nucleic acid-like compounds |
| 09/23/2014 | CA2683009C Use of il-18 inhibitors |
| 09/23/2014 | CA2517101C A modified oligonucleotide for inhibition of growth hormone receptor expression |
| 09/23/2014 | CA2454822C Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a |
| 09/23/2014 | CA2441815C Method and composition for treatment of skeletal dysplasias |
| 09/23/2014 | CA2398995C Lipid hydrolysis therapy for atherosclerosis and related diseases |
| 09/18/2014 | WO2014146097A1 Compositions for treatment and/or prevention of autoimmune disorders |
| 09/18/2014 | WO2014146044A1 Administration of nicotinamide mononucleotide in the treatment of disease |
| 09/18/2014 | WO2014145923A2 Synthetic immunogens for prophylaxis or treatment of tuberculosis |
| 09/18/2014 | WO2014145261A2 Methods and compositions for in vivo immune stimulation and antigen production |
| 09/18/2014 | WO2014145254A2 Falz for use as a target for therapies to treat cancer |
| 09/18/2014 | WO2014145236A2 The use of sdf-1 to mitigate scar formation |
| 09/18/2014 | WO2014145225A1 Sdf-1 delivery for treating ischemic tissue |
| 09/18/2014 | WO2014145199A2 Retrograde delivery of sdf-1 for treatment of myocardial infarction |
| 09/18/2014 | WO2014145042A1 Treatment of autoimmune diseases |
| 09/18/2014 | WO2014144799A2 siRNA TARGETING HSR1 |
| 09/18/2014 | WO2014144486A2 Vectors comprising stuffer/filler polynucleotide sequences and methods of use |
| 09/18/2014 | WO2014144442A2 Antisense molecules for treatment of staphylococcus aureus infection |
| 09/18/2014 | WO2014144423A2 Antisense molecules for treatment of staphylococcus aureus infection |
| 09/18/2014 | WO2014144229A1 Methods and compositions for dual glycan binding aav vectors |
| 09/18/2014 | WO2014144130A2 Pharmaceutical composition comprising an ampk activator and a serotonergic agent and methods of use thereof |
| 09/18/2014 | WO2014143022A1 Compositions and methods for treating retinal disease |
| 09/18/2014 | WO2014142235A1 Microvesicle, and manufacturing method for same |
| 09/18/2014 | WO2014141288A1 The art, method, manner, process and system of a nano-biomineral for multi-modal contrast imaging and drug delivery |
| 09/18/2014 | WO2014141287A1 The art, method, manner, process and system of multifunctional nanobiomaterial for molecular imaging and drug- delivery |
| 09/18/2014 | WO2014140797A1 MicroRNA-BASED APPROACH TO TREATING MALIGNANT PLEURAL MESOTHELIOMA |
| 09/18/2014 | WO2014140645A1 Stable aqueous formulations of adenovirus vectors |
| 09/18/2014 | WO2014140333A1 Methods of treating colorectal cancer |
| 09/18/2014 | WO2014139443A1 Low immunogenicity human cell and preparation method therefor |
| 09/18/2014 | US20140275231 Chimeric promoter for cone photoreceptor targeted gene therapy |
| 09/18/2014 | US20140275230 Methods and compositions for increasing sialic acid production and treating sialic related disease conditions |
| 09/18/2014 | US20140275225 Modulators of pharmacological agents |
| 09/18/2014 | US20140275212 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 09/18/2014 | US20140271868 Treatment of achondroplasia with encapsulated cnp-secreting cells |
| 09/18/2014 | US20140271549 Use of Antibiotics to Enhance Treatment With Therapeutic Viruses |
| 09/17/2014 | EP2776459A1 Rod cell-specific promoter |
| 09/17/2014 | EP2776071A1 Transcription factor-based generation of pacemaker cells and methods of using same |
| 09/17/2014 | EP2776064A1 Provasopressin antagonists and uses thereof |
| 09/16/2014 | US8835617 Polynucleotides encoding a human TRIM-Cyp fusion polypeptide, compositions thereof, and methods of using same |
| 09/16/2014 | US8835401 Treatment of cancer by inhibition of IGFBPs and clusterin |
| 09/16/2014 | US8835400 RNA molecules that upregulate insulin production |
| 09/16/2014 | US8835398 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 09/16/2014 | US8835387 Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases |
| 09/16/2014 | US8835112 Cell transdifferentiation into brown adipocytes |
| 09/16/2014 | US8835108 RNA containing modified nucleosides and methods of use thereof |
| 09/16/2014 | US8834900 Combination motif immune stimulatory oligonucleotides with improved activity |
| 09/16/2014 | US8834884 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| 09/16/2014 | CA2570887C Tumor treatment |
| 09/16/2014 | CA2529798C Methods of treating hepatocellular carcinoma with zvegf3 antagonists |
| 09/16/2014 | CA2510309C Recombinant vaccine viruses expressing il-15 and methods of using the same |
| 09/16/2014 | CA2492556C Hsp70 from arthrobacter |
| 09/16/2014 | CA2484420C Antibodies specific for human cd22 and their therapeutic and diagnostic uses |
| 09/16/2014 | CA2445796C Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 09/12/2014 | WO2014138727A1 Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein c receptors (epcr) |
| 09/12/2014 | WO2014138578A1 Compositions and methods for reducing skin pigmentation |
| 09/12/2014 | WO2014138209A1 Cytomegalovirus vectors enabling control of t cell targeting |
| 09/12/2014 | WO2014134797A1 Lipidosome preparation, preparation method and application thereof |
| 09/11/2014 | US20140256800 Fev mini-promoters |
| 09/11/2014 | US20140256788 Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical Field |
| 09/11/2014 | US20140256652 Polypeptides Involved In Immune Response |
| 09/10/2014 | EP2774991A1 Drug delivery system for use in the treatment or diagnosis of neurological disorders |
| 09/10/2014 | EP2774989A1 Double-stranded nucleic acid molecule for gene expression control |
| 09/10/2014 | EP2773382A1 Co-activation of mtor and stat3 pathways to promote neuronal survival and regeneration |
| 09/10/2014 | EP2773381A2 Methods of using microrna 195 in providing neuroprotection |
| 09/10/2014 | EP2773380A2 Method for de-differentiating a cell |
| 09/09/2014 | US8829264 Methods and compositions for RNA interference |
| 09/09/2014 | US8829179 Means for inhibiting the expression of ANG2 |
| 09/09/2014 | US8829176 Beta-actin and RPS21 promoters and uses thereof |
| 09/09/2014 | US8829173 Recombinant vectors |
| 09/09/2014 | US8828965 MiR-150 for the treatment of blood disorders |
| 09/09/2014 | US8828963 Diagnosis and treatment of chronic lymphocytic leukemia (CLL) |
| 09/09/2014 | US8828959 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 09/09/2014 | US8828957 Methods for generating immunity to antigen |
| 09/09/2014 | US8828934 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/09/2014 | US8828928 Amphiphilic peptides and peptide particles |
| 09/09/2014 | US8828726 Circular nucleic acid vectors, and methods for making and using the same |
| 09/09/2014 | US8828652 Elimination of N-glycolylneuraminic acid from animal products for human use |
| 09/09/2014 | US8828405 Method to enhance an immune response of nucleic acid vaccination |
| 09/09/2014 | US8828385 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 09/09/2014 | US8828378 Targeted vectors for cancer immunotherapy |
| 09/09/2014 | CA2660324C Plasmids with immunological action |
| 09/09/2014 | CA2400256C Compositions useful for regulating parkin gene activity |
| 09/04/2014 | WO2014134403A2 Aptamers that bind cd271 |
| 09/04/2014 | WO2014134187A1 Compositions and methods for the treatment of cancer |
| 09/04/2014 | WO2014134084A2 Phf20 and jmjd3 compositions and methods of use in cancer immunotherapy |
| 09/04/2014 | WO2014134029A1 Nucleic acid particles, methods and use thereof |
| 09/04/2014 | WO2014133351A1 Composition for gene delivery comprising chitosan and liquid crystal formation material |
| 09/04/2014 | WO2014132671A1 Chimeric single-stranded antisense polynucleotides and double-stranded antisense agent |
| 09/04/2014 | WO2013090457A3 In vivo delivery of oligonucleotides |
| 09/04/2014 | WO2013066485A3 Compositions and methods for treatment of metastatic cancer |
| 09/04/2014 | US20140249211 Systemic Gene Replacement Therapy for Treatment of X-Linked MyoTubular Myopathy (XLMTM) |
| 09/04/2014 | DE10297513C5 In vitro Herstellung von dendritischen Zellen aus CD14+ Monocyten In vitro production of dendritic cells from CD14 + monocytes |
| 09/03/2014 | EP2772251A1 Protamine/RNA nanoparticles for immunostimulation |
| 09/03/2014 | EP2771471A1 Construct |
| 09/03/2014 | EP2771350A1 Topk peptides and vaccines including the same |
| 09/03/2014 | EP2771319A1 Amino acid derivatives functionalized on the n- terminal capable of forming drug incapsulating microspheres |